Cyclophosphamide for scleroderma lung disease.
Martinez
Fernando J
FJ
McCune
W Joseph
WJ
D001327:Autoimmune Diseases / Q000188:drug therapy; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017563:Lung Diseases, Interstitial / Q000188:drug therapy* / Q000276:immunology; D009369:Neoplasms / Q000139:chemically induced; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000276:immunology; D001745:Urinary Bladder Diseases / Q000139:chemically induced; D014797:Vital Capacity / Q000187:drug effects
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide